Brief: Armata Pharmaceuticals Announces New Financing And Leadership Transition

Innoviva

11/07/2023 13:10

July 11 (Reuters) - Armata Pharmaceuticals Inc  ARMP.A :
    * ARMATA PHARMACEUTICALS ANNOUNCES NEW FINANCING AND
LEADERSHIP
TRANSITION TO ACCELERATE NOVEL BACTERIOPHAGE THERAPEUTICS
    * SAYS APPOINTS DEBORAH L. BIRX AS CHIEF EXECUTIVE OFFICER
    * SAYS SIGNS NEW $25 MILLION CREDIT AGREEMENT AND EXTENSION
OF
EXISTING SECURED CONVERTIBLE CREDIT AGREEMENT
    * SAYS DEBORAH L. BIRX WILL SUCCEED DR. BRIAN VARNUM AS
CHIEF
EXECUTIVE OFFICER OF COMPANY, EFFECTIVE IMMEDIATELY

Source text for Eikon:  ID:nPn57z2wna 
Further company coverage:  ARMP.A 

 ((Reuters.Briefs@thomsonreuters.com;))